Launched in May 2020, the Index offers pharmaceutical and biotech companies an opportunity to showcase, benchmark and evaluate the quality of their communications and advocacy with patient groups. The aim is to celebrate as many companies that meet the mark, so we can raise the bar across the industry. There are no costs involved – entering the Index is completely free for everyone.
The Index will evaluate the highest standards, based on best practice, of partnerships in communications and advocacy between pharmaceutical, biotech and patient communities.
Companies are offered the opportunity to submit entries to the Index. In return, they will be recognised amongst their industry peers and patient organisations, as well as receive an exclusive insights report from OVID Health. The deadline for entries is June 23rd 2020.
The final results will be announced in the September issue of PharmaTimes and all entrants will have the opportunity to profile their involvement with the Index through their own external and internal channels.